Chemomab Therapeutics Ltd. Basic Shares Outstanding (Weighted Average)
Chemomab Therapeutics Ltd. (CMMB) reported Basic Shares Outstanding (Weighted Average) of 510.23 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-03-23
- Chemomab Therapeutics Ltd. weighted average number of shares outstanding, basic for the quarter ending 2024-06-30 was 286.08M shares, a 29.05% increase year-over-year.
- Chemomab Therapeutics Ltd. weighted average number of shares outstanding, basic for the quarter ending 2023-06-30 was 221.67M shares, a 2.85% decline year-over-year.
- Chemomab Therapeutics Ltd. weighted average number of shares outstanding, basic for the quarter ending 2023-03-31 was 221.00M shares, a 3.11% decline year-over-year.
- Chemomab Therapeutics Ltd. weighted average number of shares outstanding, basic for the quarter ending 2022-12-31 was 225.31M shares, a 7.66% decline year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2025-12-31 | 510.23M shares 20-F · filed 2026-03-23 | |||
| 2025-06-30 | 459.83M shares 6-K · filed 2025-08-14 | |||
| 2024-12-31 | 359.05M shares 20-F · filed 2026-03-23 | |||
| 2024-06-30 | 286.08M shares 6-K · filed 2024-08-21 | 285.11M shares 6-K · filed 2025-08-14 | ||
| 2023-12-31 | 235.00M shares 20-F · filed 2026-03-23 | |||
| 2023-06-30 | 221.67M shares 6-K · filed 2024-08-21 | 221.34M shares 6-K · filed 2024-08-21 | 222.66M shares derived: average of 3 quarters · filed 2025-04-04 | 224.19M shares derived: average of 4 quarters · filed 2025-04-04 |
| 2023-03-31 | 221.00M shares 10-Q · filed 2023-05-11 | 223.15M shares derived: average of 2 quarters · filed 2025-04-04 | 225.03M shares derived: average of 3 quarters · filed 2025-04-04 | 225.81M shares derived: average of 4 quarters · filed 2025-04-04 |
| 2022-12-31 | 225.31M shares derived: 20-F 12 month − 10-Q 9 month · filed 2025-04-04 | 227.04M shares derived: average of 2 quarters · filed 2025-04-04 | 227.42M shares derived: average of 3 quarters · filed 2025-04-04 | 227.59M shares 20-F · filed 2025-04-04 |
| 2022-09-30 | 228.77M shares 10-Q · filed 2022-11-10 | 228.47M shares derived: average of 2 quarters · filed 2023-08-14 | 228.35M shares 10-Q · filed 2022-11-10 | 232.26M shares derived: average of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | 228.17M shares 6-K · filed 2023-08-14 | 228.13M shares 6-K · filed 2023-08-14 | 233.42M shares derived: average of 3 quarters · filed 2024-03-28 | 232.05M shares derived: average of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | 228.09M shares 10-Q · filed 2023-05-11 | 236.04M shares derived: average of 2 quarters · filed 2024-03-28 | 233.35M shares derived: average of 3 quarters · filed 2024-03-28 | 229.08M shares derived: average of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | 244.00M shares derived: 20-F 12 month − 10-Q 9 month · filed 2024-03-28 | 235.98M shares derived: average of 2 quarters · filed 2024-03-28 | 229.41M shares derived: average of 3 quarters · filed 2024-03-28 | 207.47M shares 20-F · filed 2024-03-28 |
| 2021-09-30 | 227.96M shares 10-Q · filed 2022-11-10 | 222.11M shares derived: average of 2 quarters · filed 2022-11-10 | 195.29M shares 10-Q · filed 2022-11-10 | |
| 2021-06-30 | 216.27M shares 10-Q · filed 2022-08-12 | 186.84M shares 10-Q · filed 2022-08-12 |